Axonics Inc at RBC Capital Markets Global Healthcare Conference Transcript
Thank you, everyone, for being here today and welcome to the 2023 RBC's Global Healthcare Conference. My name is Shagun Singh. I'm a Senior Medical Device Analyst here at RBC, and I'm very pleased to have our next company here for a fireside chat, which is Axonics.
Joining us from the company are Ray Cohen, Chief Executive Officer, as well as Neil Bhalodkar, Vice President of Investor Relations. Thank you so much for being here today. We really appreciate it.
Thank you. It's a pleasure to be here. I appreciate you inviting us.
Questions & Answers
Great. So I thought we'll begin with a discussion of perhaps Q1, the latest trends and guidance since you just reported numbers. You delivered a pretty strong beat in Q1, and I think it was driven by both your businesses, which is Sacral Neuromodulation, as well as Bulkamid. Can you maybe talk a little bit about monthly trends for each
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |